Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
13
×
life sciences
biotech
national blog main
boston blog main
boston top stories
fda
boston
national top stories
san francisco blog main
deals
cancer
investing
new york blog main
san diego blog main
startups
decibel therapeutics
detroit blog main
detroit top stories
europe blog main
gene therapy
san diego top stories
san francisco top stories
atlas venture
biofourmis
black diamond therapeutics
boulder/denver blog main
boulder/denver top stories
chronic rhinosinusitis
crispr
dyne therapeutics
eli lilly
glaxosmithkline
harvard university
hearing loss
indiana blog main
indiana top stories
ipo
laurence reid
lyra therapeutics
What
therapeutics
13
×
medicines
drug
ipo
treat
ago
approved
company
developing
fda
million
new
raised
biotech
black
clinic
companies
data
debut
developed
diamond
dyne
focus
genetic
hearing
late
leading
loss
muscle
rare
regenerative
targets
therapy
time
topped
years
access
adding
address
adds
Language
unset
13
×
Current search:
" clinical trials "
×
unset
×
therapeutics
×
@techcrunch.com
2 years ago
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds